JP5634262B2
(ja)
|
2007-07-26 |
2014-12-03 |
ユニキュアー アイピー ビー.ブイ. |
差次的コドンバイアスを有する反復コード配列を含むバキュロウイルスベクター
|
US20110030075A1
(en)
|
2008-01-29 |
2011-02-03 |
Proyecto De Biomedicina Cima S.L. |
Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic Manner
|
US8642314B2
(en)
*
|
2008-02-19 |
2014-02-04 |
Amsterdam Molecular Therapeutics (Amt) B.V. |
Optimization of expression of parvoviral rep and cap proteins in insect cells
|
MX2011003229A
(es)
*
|
2008-09-29 |
2011-09-06 |
Proyecto Biomedicina Cima Sl |
Terapia genica con porfobilinogeno desaminasa.
|
JP5728389B2
(ja)
|
2009-01-30 |
2015-06-03 |
ユニキュアー アイピー ビー.ブイ. |
アラニン−グリオキシル酸アミノトランスフェラーゼ治療薬
|
EP2412387B1
(en)
|
2009-03-27 |
2014-11-19 |
Proyecto de Biomedicina Cima, S.L. |
Methods and compositions for the treatment of cirrhosis and liver fibrosis
|
EP2500434A1
(en)
*
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
TWI775096B
(zh)
|
2012-05-15 |
2022-08-21 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
SI3889173T1
(sl)
|
2013-02-15 |
2023-11-30 |
Bioverativ Therapeutics Inc. |
Optimiran gen dejavnika VIII
|
WO2015060722A1
(en)
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
CA2924013A1
(en)
|
2013-11-05 |
2015-05-14 |
Clontech Laboratories, Inc. |
Dry transfection compositions and methods for making and using the same
|
CN106459984B
(zh)
*
|
2014-03-10 |
2021-09-07 |
优尼科Ip有限公司 |
昆虫细胞中产生的进一步改善的aav载体
|
CA2942776C
(en)
|
2014-03-17 |
2023-01-24 |
Adverum Biotechnologies, Inc. |
Polyneucleotide cassette and expression vector for expression of a gene in cone cells using truncated m-opsin promoter
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
MX2017005834A
(es)
|
2014-11-05 |
2017-11-17 |
Voyager Therapeutics Inc |
Polinucleotidos aad para el tratamiento de la enfermedad de parkinson.
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
AU2015346162B2
(en)
|
2014-11-14 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
|
CN112375760A
(zh)
|
2014-11-14 |
2021-02-19 |
沃雅戈治疗公司 |
调节性多核苷酸
|
EP3224376B2
(en)
|
2014-11-28 |
2023-04-26 |
uniQure IP B.V. |
Dna impurities in a composition comprising a parvoviral virion
|
WO2016094783A1
(en)
|
2014-12-12 |
2016-06-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
LT3237618T
(lt)
|
2014-12-24 |
2019-07-10 |
Uniqure Ip B.V. |
Rnri sukeltas hantingtino geno slopinimas
|
KR20170137730A
(ko)
|
2015-03-02 |
2017-12-13 |
애드베룸 바이오테크놀로지스, 인코포레이티드 |
망막 추상체에 폴리뉴클레오타이드의 유리체 내 전달을 위한 조성물 및 방법
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
JP7217630B2
(ja)
|
2016-02-01 |
2023-02-03 |
バイオベラティブ セラピューティクス インコーポレイテッド |
最適化第viii因子遺伝子
|
PT3436593T
(pt)
|
2016-03-28 |
2023-01-31 |
Ultragenyx Pharmaceutical Inc |
Métodos de inativação pelo calor de adenovírus
|
KR102598289B1
(ko)
*
|
2016-04-16 |
2023-11-06 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
바큘로바이러스 시스템-생산된 재조합 아데노-연관 바이러스의 생물학적 효력을 증진시키는 방법
|
WO2017189959A1
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR THE TREATMENT OF DISEASES
|
CN115925999A
(zh)
|
2016-05-13 |
2023-04-07 |
4D分子治疗有限公司 |
腺相关病毒变体衣壳和其使用方法
|
SG11201809699XA
(en)
|
2016-05-18 |
2018-12-28 |
Voyager Therapeutics Inc |
Modulatory polynucleotides
|
RU2764587C2
(ru)
|
2016-05-18 |
2022-01-18 |
Вояджер Терапьютикс, Инк. |
Способы и композиции для лечения хореи гентингтона
|
KR20190020745A
(ko)
*
|
2016-06-15 |
2019-03-04 |
옥스포드 유니버시티 이노베이션 리미티드 |
Abc4a를 발현시키기 위한 이중 중첩 아데노-관련 바이러스 벡터 시스템
|
TN2019000047A1
(en)
*
|
2016-08-15 |
2020-07-15 |
Genzyme Corp |
Methods for detecting aav
|
JP2019530737A
(ja)
|
2016-08-23 |
2019-10-24 |
アコーオス インコーポレイテッド |
ヒト対象において非加齢性聴力障害を治療するための組成物および方法
|
US11298041B2
(en)
|
2016-08-30 |
2022-04-12 |
The Regents Of The University Of California |
Methods for biomedical targeting and delivery and devices and systems for practicing the same
|
US11795473B2
(en)
|
2016-10-14 |
2023-10-24 |
Ultragenyx Pharmaceutical Inc. |
Use of tonicifying agents to enhance recombinant adeno-associated virus yield
|
AU2017378191A1
(en)
|
2016-12-16 |
2019-07-04 |
Uniqure Ip B.V. |
Immunoadsorption
|
CN110462037A
(zh)
*
|
2017-01-30 |
2019-11-15 |
学校法人日本医科大学 |
腺相关病毒(aav)衣壳蛋白的突变体
|
US11898170B2
(en)
|
2017-03-22 |
2024-02-13 |
Ultragenyx Pharmaceutical Inc. |
Cell culture methods involving HDAC inhibitors or rep proteins
|
SG11201909868YA
(en)
|
2017-05-05 |
2019-11-28 |
Voyager Therapeutics Inc |
Compositions and methods of treating huntington's disease
|
JP2020518258A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
筋萎縮性側索硬化症(als)治療組成物および方法
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
IL271957B2
(en)
|
2017-07-10 |
2024-02-01 |
Uniqure Ip Bv |
Means and methods for AAV-based gene therapy
|
CN111132626B
(zh)
|
2017-07-17 |
2024-01-30 |
沃雅戈治疗公司 |
轨迹阵列引导***
|
CN111183225B
(zh)
|
2017-07-20 |
2023-11-17 |
优尼科Ip有限公司 |
在昆虫细胞中改进的aav衣壳产生
|
KR20200044793A
(ko)
|
2017-08-03 |
2020-04-29 |
보이저 테라퓨틱스, 인크. |
Aav의 전달을 위한 조성물 및 방법
|
WO2019060454A2
(en)
|
2017-09-20 |
2019-03-28 |
4D Molecular Therapeutics Inc. |
CAPSID VARIANT ADENO-ASSOCIATED VIRUSES AND METHODS OF USE
|
US20200231986A1
(en)
|
2017-09-29 |
2020-07-23 |
Massachusetts Eye And Ear Infirmary |
Production of adeno-associated viruses in insect cells
|
WO2019079242A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
JP2021502060A
(ja)
|
2017-10-16 |
2021-01-28 |
ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. |
筋萎縮性側索硬化症(als)の治療
|
ES2946747T3
(es)
|
2017-11-27 |
2023-07-25 |
4D Molecular Therapeutics Inc |
Variantes de cápsides de virus adenoasociado y su utilización para inhibir la angiogénesis
|
AU2018394287A1
(en)
|
2017-12-29 |
2020-06-18 |
Uniqure Ip B.V. |
Modified viral vectors and methods of making and using the same
|
ES2957622T3
(es)
|
2018-01-17 |
2024-01-23 |
Meiragtx Uk Ii Ltd |
Proteína de cápside de rAAV modificada para terapia génica
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
WO2019161365A1
(en)
|
2018-02-19 |
2019-08-22 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring f8 gene function and methods of use thereof
|
US20210230632A1
(en)
|
2018-05-15 |
2021-07-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
SG11202011296VA
(en)
|
2018-05-15 |
2020-12-30 |
Voyager Therapeutics Inc |
Compositions and methods for the treatment of parkinson's disease
|
WO2019222441A1
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
US20210214749A1
(en)
|
2018-05-16 |
2021-07-15 |
Voyager Therapeutics, Inc. |
Directed evolution
|
EP3807404A1
(en)
|
2018-06-13 |
2021-04-21 |
Voyager Therapeutics, Inc. |
Engineered 5' untranslated regions (5' utr) for aav production
|
US20210355454A1
(en)
|
2018-07-24 |
2021-11-18 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
US20210277418A1
(en)
|
2018-08-03 |
2021-09-09 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
WO2020053258A1
(en)
|
2018-09-12 |
2020-03-19 |
Uniqure Ip B.V. |
Rnai induced c9orf72 suppression for the treatment of als/ftd
|
KR20210068068A
(ko)
|
2018-09-28 |
2021-06-08 |
보이저 테라퓨틱스, 인크. |
조작된 프로모터를 갖는 프라탁신 발현 구축물 및 그의 사용 방법
|
US20210348242A1
(en)
|
2018-10-04 |
2021-11-11 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
TW202028458A
(zh)
|
2018-10-05 |
2020-08-01 |
美商航海家醫療公司 |
編碼腺相關病毒(aav)生產蛋白之經基因工程化核酸構築體
|
US20210371470A1
(en)
|
2018-10-12 |
2021-12-02 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
EP3867389A1
(en)
|
2018-10-15 |
2021-08-25 |
Voyager Therapeutics, Inc. |
Expression vectors for large-scale production of raav in the baculovirus/sf9 system
|
US11702673B2
(en)
|
2018-10-18 |
2023-07-18 |
University Of Florida Research Foundation, Incorporated |
Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
|
WO2020104435A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Ip B.V. |
A companion diagnostic to monitor the effects of gene therapy
|
CN113383077A
(zh)
|
2018-11-19 |
2021-09-10 |
优尼科Ip有限公司 |
RNAi诱导的ataxin-3减少以用于治疗脊髓小脑共济失调3型
|
WO2020104480A1
(en)
|
2018-11-19 |
2020-05-28 |
Uniqure Biopharma B.V. |
Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
|
AU2019382824A1
(en)
|
2018-11-19 |
2021-06-03 |
Uniqure Ip B.V. |
Method and means to deliver miRNA to target cells
|
AU2020208467A1
(en)
|
2019-01-18 |
2021-08-05 |
Voyager Therapeutics, Inc. |
Methods and systems for producing AAV particles
|
SG11202108614QA
(en)
|
2019-02-15 |
2021-09-29 |
Sangamo Therapeutics Inc |
Compositions and methods for producing recombinant aav
|
CR20210444A
(es)
|
2019-02-25 |
2021-11-02 |
Novartis Ag |
Composiciones y métodos para tratar distrofia cristalina de bietti
|
WO2020174369A2
(en)
|
2019-02-25 |
2020-09-03 |
Novartis Ag |
Compositions and methods to treat bietti crystalline dystrophy
|
CN113631706A
(zh)
*
|
2019-02-28 |
2021-11-09 |
贝尼泰克知识产权控股股份有限公司 |
用于治疗眼咽肌营养不良(opmd)的组合物和方法
|
US20220186193A1
(en)
*
|
2019-04-12 |
2022-06-16 |
Massachusetts Eye & Ear Infirmary |
METHODS AND COMPOSITIONS FOR IMPROVING THE ASSEMBLY OF ADENO-ASSOCIATED VIRUSES (AAVs)
|
SG11202110904PA
(en)
|
2019-04-12 |
2021-10-28 |
Ultragenyx Pharmaceutical Inc |
Engineered producer cell lines and methods of making and using the same
|
TW202106879A
(zh)
|
2019-04-29 |
2021-02-16 |
美商航海家醫療公司 |
於生物反應器中生產經桿狀病毒感染之昆蟲細胞(biic)之系統及方法
|
BR112022000724A2
(pt)
|
2019-07-15 |
2022-06-14 |
Meiragtx Uk Ii Ltd |
Proteínas de capsídeo de aav modificado para tratamento de doença artrítica
|
US10801042B1
(en)
|
2019-07-15 |
2020-10-13 |
Vigene Biosciences, Inc. |
Use of ion concentrations to increase the packaging efficiency of recombinant adeno-associated virus
|
US10653731B1
(en)
|
2019-07-15 |
2020-05-19 |
Vigene Biosciences Inc. |
Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
|
US10557149B1
(en)
*
|
2019-07-15 |
2020-02-11 |
Vigene Biosciences, Inc. |
Recombinantly-modified adeno-associated virus helper vectors and their use to improve the packaging efficiency of recombinantly-modified adeno-associated virus
|
WO2021025995A1
(en)
|
2019-08-02 |
2021-02-11 |
Voyager Therapeutics, Inc. |
Aav variants with enhanced tropism
|
EP4010465A1
(en)
|
2019-08-09 |
2022-06-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
US20220364114A1
(en)
|
2019-08-26 |
2022-11-17 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
WO2021046155A1
(en)
|
2019-09-03 |
2021-03-11 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
WO2021053018A1
(en)
|
2019-09-16 |
2021-03-25 |
Uniqure Ip B.V. |
Targeting misspliced transcripts in genetic disorders
|
WO2021072129A2
(en)
|
2019-10-08 |
2021-04-15 |
Trustees Of Boston College |
Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins
|
AU2020398178A1
(en)
|
2019-12-04 |
2022-06-09 |
Sangamo Therapeutics, Inc. |
Novel compositions and methods for producing recombinant AAV
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
AU2021225035A1
(en)
|
2020-02-21 |
2022-10-13 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
KR20220150353A
(ko)
|
2020-03-05 |
2022-11-10 |
네오티엑스 테라퓨틱스 엘티디. |
면역 세포를 사용하여 암을 치료하기 위한 방법 및 조성물
|
BR112022018658A2
(pt)
|
2020-03-16 |
2022-12-20 |
Ultragenyx Pharmaceutical Inc |
Métodos para potencializar o rendimento de vírus adenoassociado recombinante
|
CN115867647A
(zh)
|
2020-04-02 |
2023-03-28 |
优尼科生物制药有限公司 |
新型细胞系
|
CA3169087A1
(en)
|
2020-04-02 |
2021-10-07 |
David Johannes Francois DU PLESSIS |
Dual bifunctional vectors for aav production
|
EP4133074A1
(en)
|
2020-04-07 |
2023-02-15 |
uniQure IP B.V. |
Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereof
|
BR112022020753A2
(pt)
|
2020-04-15 |
2022-12-20 |
Voyager Therapeutics Inc |
Compostos de ligação a tau
|
WO2021230987A1
(en)
|
2020-05-13 |
2021-11-18 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
WO2022026410A2
(en)
|
2020-07-27 |
2022-02-03 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
US20230227802A1
(en)
|
2020-07-27 |
2023-07-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
EP4192514A1
(en)
|
2020-08-06 |
2023-06-14 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
CN112725344B
(zh)
*
|
2020-12-28 |
2023-05-12 |
中吉智药(南京)生物技术有限公司 |
密码子优化的smn1基因、腺相关病毒表达质粒及基因药物
|
WO2022187473A2
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
CN115427561A
(zh)
|
2021-03-09 |
2022-12-02 |
辉大(上海)生物科技有限公司 |
工程化CRISPR/Cas13***及其用途
|
WO2022207899A1
(en)
|
2021-04-02 |
2022-10-06 |
Uniqure Biopharma B.V. |
Methods for producing single insect cell clones
|
WO2022214635A1
(en)
|
2021-04-08 |
2022-10-13 |
Stichting Vu |
Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
|
WO2022253955A2
(en)
|
2021-06-02 |
2022-12-08 |
Uniqure Biopharma B.V. |
Insect cell production of parvoviral vectors with modified capsid proteins
|
EP4347849A1
(en)
|
2021-06-02 |
2024-04-10 |
uniQure biopharma B.V. |
Adeno-associated virus vectors modified to bind high-density lipoprotein
|
CN117836010A
(zh)
|
2021-06-21 |
2024-04-05 |
优尼科生物制药有限公司 |
改进的裂解程序
|
EP4359525A1
(en)
|
2021-06-21 |
2024-05-01 |
uniQure biopharma B.V. |
Gene constructs for silencing alpha-synuclein and uses thereof
|
EP4359547A1
(en)
*
|
2021-06-22 |
2024-05-01 |
Pfizer Inc. |
Production of adeno-associated virus vector in insect cells
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
WO2023025920A1
(en)
|
2021-08-26 |
2023-03-02 |
Uniqure Biopharma B.V. |
Insect cell-produced high potency aav vectors with cns-tropism
|
WO2023044483A2
(en)
|
2021-09-20 |
2023-03-23 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
WO2023077078A1
(en)
|
2021-10-29 |
2023-05-04 |
Ultragenyx Pharmaceutical Inc. |
Engineered cell lines for increased production of recombinant adeno-associated virus (raav)
|
TW202334436A
(zh)
|
2021-11-02 |
2023-09-01 |
美商航海家醫療公司 |
Aav衣殼變異體及其用途
|
CN114107390B
(zh)
*
|
2021-11-05 |
2023-10-24 |
中国科学院精密测量科学与技术创新研究院 |
一种用于表达抗体IgG1的rAAV载体及其应用
|
WO2023091949A2
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
WO2023091948A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2023147374A2
(en)
|
2022-01-25 |
2023-08-03 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
TW202346599A
(zh)
|
2022-02-08 |
2023-12-01 |
美商航海家醫療公司 |
Aav衣殼變異體及其用途
|
WO2023198662A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Novel systems for nucleic acid regulation
|
WO2023198745A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of apoe
|
WO2023198663A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of snca
|
WO2023198702A1
(en)
|
2022-04-12 |
2023-10-19 |
Uniqure Biopharma B.V. |
Nucleic acid regulation of c9orf72
|
WO2023235791A1
(en)
|
2022-06-02 |
2023-12-07 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
WO2024006741A1
(en)
|
2022-06-28 |
2024-01-04 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2024011112A1
(en)
|
2022-07-06 |
2024-01-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
WO2024030976A2
(en)
|
2022-08-03 |
2024-02-08 |
Voyager Therapeutics, Inc. |
Compositions and methods for crossing the blood brain barrier
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
WO2024059739A1
(en)
|
2022-09-15 |
2024-03-21 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
CN116622742A
(zh)
*
|
2022-09-27 |
2023-08-22 |
睿征医药科技(武汉)有限公司 |
一种用于在昆虫细胞中产生rAAV的核酸、VP1衣壳蛋白突变体及应用
|
EP4349990A1
(en)
*
|
2022-10-07 |
2024-04-10 |
Certest Biotec, S.L. |
Artificial polynucleotides for expressing proteins
|
CN117343943A
(zh)
*
|
2022-10-13 |
2024-01-05 |
康霖生物科技(杭州)有限公司 |
腺相关病毒的衣壳蛋白编码基因改造方法
|